Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
SC Pharmaceuticals Inc
(NQ:
SCPH
)
5.190
+0.130 (+2.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about SC Pharmaceuticals Inc
< Previous
1
2
3
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 22, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 21, 2022
Via
Benzinga
Analyst Ratings for scPharmaceuticals
November 10, 2022
Within the last quarter, scPharmaceuticals (NASDAQ:SCPH) has observed the following analyst ratings:
Via
Benzinga
Expert Ratings for scPharmaceuticals
November 10, 2022
Analysts have provided the following ratings for scPharmaceuticals (NASDAQ:SCPH) within the last quarter:
Via
Benzinga
Short Volatility Alert: AscPharmaceuticals Inc.
October 13, 2022
On Wednesday, shares of scPharmaceuticals Inc. (NASDAQ: SCPH) experienced volatile short activity. After the activity, the stock price went up +1.75% to $5.70. The overall sentiment for SCPH has been...
Via
Benzinga
US Stocks Open Lower, Dow Falls 100 Points
October 11, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Tuesday.
Via
Benzinga
FDA Approves scPharmaceuticals' Self-Administered Med For Congestion in Chronic Heart Failure
October 10, 2022
Via
Benzinga
Recap: scPharmaceuticals Q1 Earnings
May 16, 2022
scPharmaceuticals (NASDAQ:SCPH) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
August 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
October 12, 2022
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.
Via
Benzinga
Alphabet To $134? Plus This Analyst Slashes Price Target On McDonald's
October 11, 2022
Credit Suisse cut the price target on Alphabet Inc. (NASDAQ: GOOGL) from $140 to $134. Credit Suisse analyst Stephen Ju maintained an Outperform rating on the stock. Alphabet shares fell 1.2% to $96.69...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
Upgrades
Via
Benzinga
Bilibili, H World Group And Other Big Losers From Monday
October 11, 2022
U.S. stocks closed lower with the Nasdaq Composite dropping more than 100 points on Monday. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
October 11, 2022
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued...
Via
Benzinga
Dow Rises 30 Points; Crude Oil Down 2%
October 10, 2022
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 30 points on Monday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 10, 2022
Gainers
Via
Benzinga
Wall Street Pulls Back As Chip Stocks Dent Nasdaq
October 10, 2022
Falling semiconductor stocks are weighing on the Nasdaq Composite (IXIC) this afternoon, with the tech-laden benchmark hitting its lowest level since September 2020.
Via
Talk Markets
Why Is ACM Research (ACMR) Stock Down 26% Today?
October 10, 2022
ACM Research (ACMR) stock is taking a beating on Monday after the U.S. placed restrictions on exports of certain chip technology.
Via
InvestorPlace
Why Is Applied DNA (APDN) Stock Up 70% Today?
October 10, 2022
Applied DNA (APDN) stock is rocketing higher on Monday after the company announced a massive order for its LinearDNA product.
Via
InvestorPlace
Nasdaq Dips 150 Points; Gold Down 2%
October 10, 2022
U.S. stocks pared gains midway through trading, with the Dow Jones dropping more than 100 points on Monday.
Via
Benzinga
Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session
October 10, 2022
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the...
Via
Benzinga
Why Is scPharmaceuticals (SCPH) Stock in the Spotlight Today?
October 10, 2022
It's a good-news, bad-news situation for SCPH stock today, but mostly bad news as scPharmaceuticals agrees to take on high-interest debt.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 10, 2022
Gainers NeuroMetrix (NASDAQ:NURO) shares increased by 23.0% to $3.48 during Monday's pre-market session. The company's market cap stands at $24.8 million.
Via
Benzinga
Why Myovant Sciences Is Trading Higher By Over 26%; Here Are 31 Stocks Moving Premarket
October 03, 2022
Gainers Wearable Devices Ltd. (NASDAQ: WLDS) rose 58% to $1.39 in pre-market trading after declining around 8% on Friday. Wearable Devices, last week, posted a 1H loss of $0.18 per share.
Via
Benzinga
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
October 02, 2022
Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
August 02, 2022
Upgrades
Via
Benzinga
scPharmaceuticals Shares Are Trading High Following FDA's Acceptance of NDA for FUROSCIX
May 16, 2022
scPharmaceuticals Inc. (NASDAQ: SCPH) announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) of the drug candidate FUROSCIX, for the treatment of...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
September 09, 2021
Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE:
Via
Benzinga
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
August 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues
July 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.